1. Home
  2. DERM vs HGBL Comparison

DERM vs HGBL Comparison

Compare DERM & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • HGBL
  • Stock Information
  • Founded
  • DERM 2014
  • HGBL 1937
  • Country
  • DERM United States
  • HGBL United States
  • Employees
  • DERM N/A
  • HGBL N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • HGBL Business Services
  • Sector
  • DERM Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • DERM Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • DERM 87.4M
  • HGBL 72.0M
  • IPO Year
  • DERM 2021
  • HGBL N/A
  • Fundamental
  • Price
  • DERM $3.74
  • HGBL $2.04
  • Analyst Decision
  • DERM Strong Buy
  • HGBL
  • Analyst Count
  • DERM 3
  • HGBL 0
  • Target Price
  • DERM $9.50
  • HGBL N/A
  • AVG Volume (30 Days)
  • DERM 61.7K
  • HGBL 101.9K
  • Earning Date
  • DERM 11-12-2024
  • HGBL 03-13-2025
  • Dividend Yield
  • DERM N/A
  • HGBL N/A
  • EPS Growth
  • DERM N/A
  • HGBL N/A
  • EPS
  • DERM N/A
  • HGBL 0.27
  • Revenue
  • DERM $57,771,000.00
  • HGBL $49,878,000.00
  • Revenue This Year
  • DERM N/A
  • HGBL N/A
  • Revenue Next Year
  • DERM $36.49
  • HGBL $19.47
  • P/E Ratio
  • DERM N/A
  • HGBL $7.54
  • Revenue Growth
  • DERM N/A
  • HGBL N/A
  • 52 Week Low
  • DERM $2.85
  • HGBL $1.52
  • 52 Week High
  • DERM $6.89
  • HGBL $3.09
  • Technical
  • Relative Strength Index (RSI)
  • DERM 32.80
  • HGBL 70.97
  • Support Level
  • DERM $3.54
  • HGBL $2.02
  • Resistance Level
  • DERM $3.99
  • HGBL $2.12
  • Average True Range (ATR)
  • DERM 0.35
  • HGBL 0.09
  • MACD
  • DERM 0.00
  • HGBL 0.01
  • Stochastic Oscillator
  • DERM 21.28
  • HGBL 80.49

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: